Belite Bio, Inc. (BLTE)
Belite Bio Market Cap : 6.682B for March 2, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Ionis Pharmaceuticals, Inc. | 13.27B |
| Ligand Pharmaceuticals, Inc. | 3.976B |
| Ocugen, Inc. | 633.36M |
| IDEAYA Biosciences, Inc. | 2.900B |
| Terns Pharmaceuticals, Inc. | 3.785B |
Market Cap Related Metrics
| PEG Ratio | -1.266 |
| Price to Book Value | 24.38 |
| Price | 178.12 |
| Earnings Yield | -1.08% |
| PEGY Ratio | -1.266 |